Evaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus

Evaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus

Main Article Content

Daimi Casanova Moreno
Dra. María Casanova Moreno
Ismary Acosta Martínez
Dra. Jessica González Casanova
Francisco Machado Reyes

Abstract

Errors in the prescription of drug treatment for type 2 diabetes are detected at the primary level of care. the purpose of this study was to evaluate the quality of the prescription of oral hypoglycemic agents in patients attended in the family doctor's offices of the Hermanos Cruz University Polyclinic, Pinar del Río distrit, Cuba. A descriptive and cross-sectional study of the use of medications was carried out, classified within these as indication-prescription with elements of the therapeutic scheme and factors that condition prescription habits. The universe was made up of 1575 patients diagnosed with type 2 diabetes mellitus treated with oral hypoglycemic agents who belonged to the 20 family medical offices. The study sample was carried out by the non-probabilistic sampling method (for convenience) (n = 846). The information was obtained from the clinical history and control card of the patients to acquire these medications. The age of 40-49 years, the female sex and between 5-10 years of evolution of the disease predominated. The first line of treatment was not used in 43.6% of the cases; no case had laboratory studies for the use of Metformin. The prescription and dose was adequate, but not its rational use. The most frequent interactions were pharmacokinetic ones. The rational use of oral hypoglycemic agents was deficient, which makes it necessary to expand the dissemination of a treatment protocol to improve the use of these drugs at the primary level of care.

References

Acosta Martínez, I., Casanova Moreno, M. de la C., Casanova Moreno, D., González Casanova, J. M., & Machado Reyes, F. (2020). Caracterización de la prescripción de ansiolíticos en adultos mayores institucionalizados en un Hogar de Ancianos . International Journal of Medical and Surgical Sciences, 8(1), 1-12. https://doi.org/10.32457/ijmss.v8i1.633

Angles, E. (2018) Uso racional de antimicrobianos y resistencia bacteriana: ¿hacia dónde vamos?. Rev Med Hered., 29(1 ): 3-4. http://www.scielo.org.pe/pdf/rmh/v29n1/a01v29n1.pdf

Arbesú Michelena, M A. (2013). La atención farmacéutica en pacientes oncológicos. Revista Cubana de Farmacia.,47(3):285-288. http://scielo.sld.cu/pdf/far/v47n3/far01313.pdf

Bonal, J; Lerany, C; Bassons, T; Ascón, P. (2002). Farmacia Clínica y Atención Farmacéutica. En: Farmacia Hospitalaria Cap. 2.1. 3ª ed. Madrid: Doyma; p. 275-93. Disponible en: https://www.sefh.es/bibliotecavirtual/fhtomo1/cap21.pdf

Calabrese, AT; Coley, KC; DaPos, SV; Swanson, D; Rao, R. (2002). Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med. 162(4):434-7.https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/211194

Colectivo de autores.(2014) Formulario Nacional de Medicamentos. En: Carbó Barbado, DM; Delgado Martínez, I. Formulario Nacional de Medicamentos. Vol1.4aed. Cuba: Editorial de Ciencias Médicas; p.529‐178.

Emslie-Smith, AM; Boyle, DI; Evans, J; Sullivan, F; Morris, AD.(2001) Contraindications to metformin therapy in patients with Type 2 diabetes—a population-based study of adherence to prescribing guidelines. Diabet Med.18(6):483-8. https://onlinelibrary.wiley.com/doi/epdf/10.1046/j.1464-5491.2001.00509.x

García Fariñas, A; García Mena, E; Díaz Molina, M; González Atá, A. (2016). Funcionamiento de las farmacias comunitarias del municipio Guanabacoa: recursos consumidos y resultados alcanzados, año 2012. Rev Cubana de Farmacia., 50(2): 27-3. http://www.revfarmacia.sld.cu/index.php/far/article/view/27/31

Gómez-Huelgas, R; Martínez-Castelao, A; Artola, S; Górriz, J L.(2014). Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica. Nefrología., 34(1): 34-45.http://scielo.isciii.es/pdf/nefrologia/v34n1/especial2.pdf

Jimenez Herrera, LG (2018). La política nacional de medicamentos en el contexto de América Latina. Rev Cubana Salud Pública., 44(2): 398-421. http://www.revsaludpublica.sld.cu/index.php/spu/article/view/504/1046

Lasser, KE; Seger, DL; Yu, DT; Karson, AS; Fiskio, JM; Seger, AC et al.(2006) Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med;166(3):338-44. https://pubmed.ncbi.nlm.nih.gov/16476875/

Llinás Castro, R; Alvis-Estrada, L; Castillo Ávila, I.(2017) Evaluación de la prescripción de metformina en pacientes diab éticos tipo 2 de una institución de Atención Primaria en Salud en Cartagena de Indias, Colombia. Rev Clin Med Fam., 10(1): 12-17 http://scielo.isciii.es/pdf/albacete/v10n1/original2.pdf

Marcus, M & Schindler,C. (2016). Clinically and pharmacologically relevant interactions of antidiabetic drugs Ther AdvEndocrinol Metab.; 7(2): 69-83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821002/pdf/10.1177_2042018816638050.pdf

Osorio, G;Vélez Álvarez, C. (2013) , La Atención Primaria de Salud: desafíos para su implementación en América Latina Atención Primaria., 45(7): 384-392,2013.https://www.sciencedirect.com/science/article/pii/S0212656713000413

Reyes Sanamé, F A; Pérez Álvarez, M L; Alfonso Figueredo, E; Ramírez Estupiñan, M; Jiménez Rizo, Y.(2016). Tratamiento actual de la diabetes mellitus tipo 2. CCM., 20(1): 98-12. http://www.revcocmed.sld.cu/index.php/cocmed/article/view/2194/791

Rodríguez Ganen, O; García Millian, A J; Alonso Carbonell, L; León Cabrera, P.(2017). La dispensación como herramienta para lograr el uso adecuado de los medicamentos en atención primaria. Rev Cubana Med Gen Integr . 33(4) http://scielo.sld.cu/pdf/mgi/v33n4/a07_271.pdf

Sansó Soberats, FJ; Vergara Fabián, E; Pérez Peña, J; Hernández Pérez, A.(2000) Propuesta de modelo para la prescripción de medicamentos controlados por tarjeta. Rev Cubana Med Gen Integr., 16(4): 322-328. http://scielo.sld.cu/pdf/mgi/v16n4/mgi02400.pdf

Sweileh, WM.(2007) Contraindications to metformin therapy among patients with type 2 diabetes mellitus. Pharm World Sci;29(6):587-92. https://link.springer.com/article/10.1007/s11096-007-9095-1

Zerquera Trujillo, G; Vicente Sánchez, B; Rivas Alpizar, E; Costa Cruz, M. (2016). Caracterización de los pacientes diabéticos tipo 2 ingresados en el Centro de Atención al Diabético de Cienfuegos. Rev. Finlay., 6(4): 281-289, http://scielo.sld.cu/pdf/rf/v6n4/rf05406.pdf